NCT05485207View on ClinicalTrials.gov

Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Interstitial CystitisBladder Pain Syndrome
Interventions
DRUG

Transvaginal botulinum toxin A (BTA) injection

Botulinum toxin A (Botox® 100 units) will be injected into the detrusor muscle of the bladder by inserting a needle through the anterior vaginal wall.

Trial Locations (1)

94304

Urology Clinic (Stanford University), 1000 Welch Road, Suite 100, Palo Alto

All Listed Sponsors
collaborator

McCormick and Gabilan Faculty Fellowship Award

UNKNOWN

lead

Stanford University

OTHER